Status:
RECRUITING
SUTURE-CLOSURE OMENTOPEXY VERSUS OMENTOPEXY ALONE IN REPAIR OF PERFORATED PEPTIC ULCER
Lead Sponsor:
Sohag University
Conditions:
Perforated Peptic Ulcer
Eligibility:
All Genders
Phase:
NA
Brief Summary
The present study will be conducted to assess whether there is a direct benefit associated with modified-Graham's omentopexy (MGO), above and beyond the benefit associated with Graham's omentopexy (GO...
Eligibility Criteria
Inclusion
- \- All adult patients of both sexes with a clinical diagnosis of perforated peptic ulcer (gastric or duodenal) that are fit to undergo surgery.
Exclusion
- \- 1. Patients with associated bleeding ulcer (additional steps are needed to control bleeding).
- 2\. Patients with associated pathology other than perforated peptic ulcer that needs surgical intervention.
Key Trial Info
Start Date :
July 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06550856
Start Date
July 15 2024
End Date
May 1 2025
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt